Skip to main content
Top
Published in: Journal of Translational Medicine 1/2014

Open Access 01-12-2014 | Research

Increased peripheral and local soluble FGL2 in the recovery of renal ischemia reperfusion injury in a porcine kidney auto-transplantation model

Authors: Zitong Zhao, Cheng Yang, Long Li, Tian Zhao, Lingyan Wang, Ruiming Rong, Bin Yang, Ming Xu, Tongyu Zhu

Published in: Journal of Translational Medicine | Issue 1/2014

Login to get access

Abstract

Background

Regulatory T cells (Treg) protect kidney against ischemia reperfusion (IR) injury via suppressing innate immunity, but the mechanism has not been fully clarified. Soluble fibrinogen-like protein 2 (sFGL2), a novel effector of Treg, may affect apoptosis and inflammation. This study investigated the role of sFGL2 in renal IR injury in a porcine kidney auto-transplantation model.

Materials and methods

The left kidney was retrieved from mini pigs and infused by University of Wisconsin solution into the renal artery with the renal artery and vein clamped for 24-h cold storage. After the right nephrectomy, the left kidney was auto-transplanted into the right for 2 weeks. 3 pigs were sacrificed at day 2, 5, 7, 10 and 14 post-transplantation respectively. Collected renal tissues and daily blood samples were stored for further analyses.

Results

Both serum creatinine and blood urea nitrogen were maximized during day 2 to 5 and followed by a gradual recovery over 2 weeks. The similar pattern were showed in histological damage, myeloperoxidase + cells and apoptosis in the kidney, as well as circulating TNF-α and IFN-γ. Serum sFGL2 presented a fluctuating increase and reached a peak at day 10. The expression of sFGL2 and its receptor FcγRIIB as well as Foxp3 and IL-10 in the kidney was notably increased from day 5 to 10.

Conclusion

The increased sFGL2 together with FcγRIIB during renal recovery after IR injury suggested that sFGL2 might be a potential renoprotective mediator involved in the renal self-repairing and remodeling in this 2-week porcine auto-transplantation model.
Appendix
Available only for authorised users
Literature
1.
go back to reference Nankivell BJ, Kuypers DR: Diagnosis and prevention of chronic kidney allograft loss. Lancet. 2011, 378: 1428-1437. 10.1016/S0140-6736(11)60699-5.CrossRefPubMed Nankivell BJ, Kuypers DR: Diagnosis and prevention of chronic kidney allograft loss. Lancet. 2011, 378: 1428-1437. 10.1016/S0140-6736(11)60699-5.CrossRefPubMed
2.
go back to reference Ojo AO, Wolfe RA, Held PJ, Port FK, Schmouder RL: Delayed graft function: risk factors and implications for renal allograft survival. Transplantation. 1997, 63: 968-974. 10.1097/00007890-199704150-00011.CrossRefPubMed Ojo AO, Wolfe RA, Held PJ, Port FK, Schmouder RL: Delayed graft function: risk factors and implications for renal allograft survival. Transplantation. 1997, 63: 968-974. 10.1097/00007890-199704150-00011.CrossRefPubMed
3.
go back to reference Kinsey GR, Sharma R, Huang L, Li L, Vergis AL, Ye H, Ju ST, Okusa MD: Regulatory T cells suppress innate immunity in kidney ischemia-reperfusion injury. J Am Soc Nephrol. 2009, 20: 1744-1753. 10.1681/ASN.2008111160.PubMedCentralCrossRefPubMed Kinsey GR, Sharma R, Huang L, Li L, Vergis AL, Ye H, Ju ST, Okusa MD: Regulatory T cells suppress innate immunity in kidney ischemia-reperfusion injury. J Am Soc Nephrol. 2009, 20: 1744-1753. 10.1681/ASN.2008111160.PubMedCentralCrossRefPubMed
4.
go back to reference Marazzi S, Blum S, Hartmann R, Gundersen D, Schreyer M, Argraves S, von Fliedner V, Pytela R, Ruegg C: Characterization of human fibroleukin, a fibrinogen-like protein secreted by T lymphocytes. J Immunol. 1998, 161: 138-147.PubMed Marazzi S, Blum S, Hartmann R, Gundersen D, Schreyer M, Argraves S, von Fliedner V, Pytela R, Ruegg C: Characterization of human fibroleukin, a fibrinogen-like protein secreted by T lymphocytes. J Immunol. 1998, 161: 138-147.PubMed
5.
go back to reference Yuwaraj S, Ding J, Liu M, Marsden PA, Levy GA: Genomic characterization, localization, and functional expression of FGL2, the human gene encoding fibroleukin: a novel human procoagulant. Genomics. 2001, 71: 330-338. 10.1006/geno.2000.6444.CrossRefPubMed Yuwaraj S, Ding J, Liu M, Marsden PA, Levy GA: Genomic characterization, localization, and functional expression of FGL2, the human gene encoding fibroleukin: a novel human procoagulant. Genomics. 2001, 71: 330-338. 10.1006/geno.2000.6444.CrossRefPubMed
6.
go back to reference Shevach EM: Mechanisms of foxp3+ T regulatory cell-mediated suppression. Immunity. 2009, 30: 636-645. 10.1016/j.immuni.2009.04.010.CrossRefPubMed Shevach EM: Mechanisms of foxp3+ T regulatory cell-mediated suppression. Immunity. 2009, 30: 636-645. 10.1016/j.immuni.2009.04.010.CrossRefPubMed
7.
go back to reference Chan CW, Kay LS, Khadaroo RG, Chan MW, Lakatoo S, Young KJ, Zhang L, Gorczynski RM, Cattral M, Rotstein O, Levy GA: Soluble fibrinogen-like protein 2/fibroleukin exhibits immunosuppressive properties: suppressing T cell proliferation and inhibiting maturation of bone marrow-derived dendritic cells. J Immunol. 2003, 170: 4036-4044.CrossRefPubMed Chan CW, Kay LS, Khadaroo RG, Chan MW, Lakatoo S, Young KJ, Zhang L, Gorczynski RM, Cattral M, Rotstein O, Levy GA: Soluble fibrinogen-like protein 2/fibroleukin exhibits immunosuppressive properties: suppressing T cell proliferation and inhibiting maturation of bone marrow-derived dendritic cells. J Immunol. 2003, 170: 4036-4044.CrossRefPubMed
8.
go back to reference Selzner N, Liu H, Boehnert MU, Adeyi OA, Shalev I, Bartczak AM, Xue-Zhong M, Manuel J, Rotstein OD, McGilvray ID, Grant DR, Phillips MJ, Levy GA, Selzner M: FGL2/fibroleukin mediates hepatic reperfusion injury by induction of sinusoidal endothelial cell and hepatocyte apoptosis in mice. J Hepatol. 2012, 56: 153-159. 10.1016/j.jhep.2011.05.033.CrossRefPubMed Selzner N, Liu H, Boehnert MU, Adeyi OA, Shalev I, Bartczak AM, Xue-Zhong M, Manuel J, Rotstein OD, McGilvray ID, Grant DR, Phillips MJ, Levy GA, Selzner M: FGL2/fibroleukin mediates hepatic reperfusion injury by induction of sinusoidal endothelial cell and hepatocyte apoptosis in mice. J Hepatol. 2012, 56: 153-159. 10.1016/j.jhep.2011.05.033.CrossRefPubMed
9.
go back to reference Zhao Z, Yang C, Tang Q, Zhao T, Jia Y, Ma Z, Rong R, Xu M, Zhu T: Serum level of soluble fibrinogen-like protein 2 in renal allograft recipients with acute rejection: a preliminary study. Transplant Proc. 2012, 44: 2982-2985. 10.1016/j.transproceed.2012.05.082.CrossRefPubMed Zhao Z, Yang C, Tang Q, Zhao T, Jia Y, Ma Z, Rong R, Xu M, Zhu T: Serum level of soluble fibrinogen-like protein 2 in renal allograft recipients with acute rejection: a preliminary study. Transplant Proc. 2012, 44: 2982-2985. 10.1016/j.transproceed.2012.05.082.CrossRefPubMed
10.
go back to reference Zhao Z, Wang L, Yang C, Zhao T, Li L, Hu L, Wu D, Rong R, Xu M, Zhu T: Soluble FGL2 induced by tumor necrosis factor-alpha and interferon-gamma in CD4(+) T cells through MAPK pathway in human renal allograft acute rejection. J Surg Res. 2013, 184: 1114-1122. 10.1016/j.jss.2013.04.011.CrossRefPubMed Zhao Z, Wang L, Yang C, Zhao T, Li L, Hu L, Wu D, Rong R, Xu M, Zhu T: Soluble FGL2 induced by tumor necrosis factor-alpha and interferon-gamma in CD4(+) T cells through MAPK pathway in human renal allograft acute rejection. J Surg Res. 2013, 184: 1114-1122. 10.1016/j.jss.2013.04.011.CrossRefPubMed
11.
go back to reference Zhao Z, Yang C, Wang L, Li L, Zhao T, Hu L, Rong R, Xu M, Zhu T: The regulatory T cell effector soluble fibrinogen-like protein 2 induces tubular epithelial cell apoptosis in renal transplantation. Exp Biol Med (Maywood). 2014, 239 (2): 193-201. 10.1177/1535370213514921.CrossRef Zhao Z, Yang C, Wang L, Li L, Zhao T, Hu L, Rong R, Xu M, Zhu T: The regulatory T cell effector soluble fibrinogen-like protein 2 induces tubular epithelial cell apoptosis in renal transplantation. Exp Biol Med (Maywood). 2014, 239 (2): 193-201. 10.1177/1535370213514921.CrossRef
12.
go back to reference Estaquier J, Vallette F, Vayssiere JL, Mignotte B: The mitochondrial pathways of apoptosis. Adv Exp Med Biol. 2012, 942: 157-183. 10.1007/978-94-007-2869-1_7.CrossRefPubMed Estaquier J, Vallette F, Vayssiere JL, Mignotte B: The mitochondrial pathways of apoptosis. Adv Exp Med Biol. 2012, 942: 157-183. 10.1007/978-94-007-2869-1_7.CrossRefPubMed
13.
go back to reference Lieberthal W, Koh JS, Levine JS: Necrosis and apoptosis in acute renal failure. Semin Nephrol. 1998, 18: 505-518.PubMed Lieberthal W, Koh JS, Levine JS: Necrosis and apoptosis in acute renal failure. Semin Nephrol. 1998, 18: 505-518.PubMed
14.
go back to reference Du C, Guan Q, Yin Z, Masterson M, Zhong R, Jevnikar AM: Renal tubular epithelial cell apoptosis by Fas-FasL-dependent self-injury can augment renal allograft injury. Transplant Proc. 2003, 35: 2481-2482. 10.1016/j.transproceed.2003.08.031.CrossRefPubMed Du C, Guan Q, Yin Z, Masterson M, Zhong R, Jevnikar AM: Renal tubular epithelial cell apoptosis by Fas-FasL-dependent self-injury can augment renal allograft injury. Transplant Proc. 2003, 35: 2481-2482. 10.1016/j.transproceed.2003.08.031.CrossRefPubMed
15.
go back to reference Oberbauer R, Rohrmoser M, Regele H, Muhlbacher F, Mayer G: Apoptosis of tubular epithelial cells in donor kidney biopsies predicts early renal allograft function. J Am Soc Nephrol. 2006–2013, 1999: 10- Oberbauer R, Rohrmoser M, Regele H, Muhlbacher F, Mayer G: Apoptosis of tubular epithelial cells in donor kidney biopsies predicts early renal allograft function. J Am Soc Nephrol. 2006–2013, 1999: 10-
16.
go back to reference Guan Q, Nguan CY, Du C: Expression of transforming growth factor-beta1 limits renal ischemia-reperfusion injury. Transplantation. 2010, 89: 1320-1327. 10.1097/TP.0b013e3181d8e9dc.CrossRefPubMed Guan Q, Nguan CY, Du C: Expression of transforming growth factor-beta1 limits renal ischemia-reperfusion injury. Transplantation. 2010, 89: 1320-1327. 10.1097/TP.0b013e3181d8e9dc.CrossRefPubMed
17.
go back to reference Favaloro B, Allocati N, Graziano V, Di Ilio C, De Laurenzi V: Role of apoptosis in disease. Aging (Albany NY). 2012, 4: 330-349. Favaloro B, Allocati N, Graziano V, Di Ilio C, De Laurenzi V: Role of apoptosis in disease. Aging (Albany NY). 2012, 4: 330-349.
19.
go back to reference Schreinemachers MC, Doorschodt BM, Florquin S, van den Bergh Weerman MA, Reitsma JB, Lai W, Sitzia M, Minor TM, Tolba RH, van Gulik TM: Improved preservation and microcirculation with POLYSOL after transplantation in a porcine kidney autotransplantation model. Nephrol Dial Transplant. 2009, 24: 816-824.CrossRefPubMed Schreinemachers MC, Doorschodt BM, Florquin S, van den Bergh Weerman MA, Reitsma JB, Lai W, Sitzia M, Minor TM, Tolba RH, van Gulik TM: Improved preservation and microcirculation with POLYSOL after transplantation in a porcine kidney autotransplantation model. Nephrol Dial Transplant. 2009, 24: 816-824.CrossRefPubMed
20.
go back to reference Snoeijs MG, Matthijsen RA, Seeldrayers S, Marcus MA, Daemen JW, Peutz-Kootstra CJ, Buurman WA, Schurink GW, Ernest van Heurn LW: Autologous transplantation of ischemically injured kidneys in pigs. J Surg Res. 2011, 171: 844-850. 10.1016/j.jss.2010.05.064.CrossRefPubMed Snoeijs MG, Matthijsen RA, Seeldrayers S, Marcus MA, Daemen JW, Peutz-Kootstra CJ, Buurman WA, Schurink GW, Ernest van Heurn LW: Autologous transplantation of ischemically injured kidneys in pigs. J Surg Res. 2011, 171: 844-850. 10.1016/j.jss.2010.05.064.CrossRefPubMed
Metadata
Title
Increased peripheral and local soluble FGL2 in the recovery of renal ischemia reperfusion injury in a porcine kidney auto-transplantation model
Authors
Zitong Zhao
Cheng Yang
Long Li
Tian Zhao
Lingyan Wang
Ruiming Rong
Bin Yang
Ming Xu
Tongyu Zhu
Publication date
01-12-2014
Publisher
BioMed Central
Published in
Journal of Translational Medicine / Issue 1/2014
Electronic ISSN: 1479-5876
DOI
https://doi.org/10.1186/1479-5876-12-53

Other articles of this Issue 1/2014

Journal of Translational Medicine 1/2014 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.